American Society of Clinical Psychopharmacology (ASCP) Annual Meeting 2018
We're attending the 2018 ASCP Annual Meeting. We'll be there - alongside representatives from academia, the National Institutes of Health (NIH), Food and Drug Administration (FDA), European regulatory agencies and industry - to discuss the key aspects of neuropsychiatric drug development, including the impact of diagnostic changes and personalised interventions based on biomarkers or genetic information. Will we see you in Miami Beach, FL?